Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruutu

Showing results (401-410 of 483) with videos related to

Pageof 49
Sort By:
European Journal of Haematology|March 30, 2007
Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia GroupPirjo Koistinen, Riikka Räty, Maija Itälä, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemiaC D Bloomfield, L M Secker-Walker, A I Goldman, et al.
Blood|November 16, 2002
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemiaAlois Gratwohl, Ronald Brand, Jane Apperley, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1983
Cisobitan in treatment of prostatic cancer. A prospective controlled multicentre studyO Alfthan, L Andersson, P L Esposti, et al.
Bone Marrow Transplantation|March 9, 2018
Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMTZinaida Peric, Stefano Botti, Jacqui Stringer, et al.
Cancer Research|October 28, 2010
DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissueSari Jäämaa, Taija M Af Hällström, Anna Sankila, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Journal of Clinical Pathology|March 16, 2006
Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancerM Branca, C Giorgi, M Ciotti, et al.
Bone Marrow Transplantation|September 15, 2015
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMTT Ruutu, L C de Wreede, A van Biezen, et al.
Pageof 49

Showing results (401-410 of 483) with videos related to

Sort By:
Pageof 49
European Journal of Haematology|March 30, 2007
Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia GroupPirjo Koistinen, Riikka Räty, Maija Itälä, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemiaC D Bloomfield, L M Secker-Walker, A I Goldman, et al.
Blood|November 16, 2002
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemiaAlois Gratwohl, Ronald Brand, Jane Apperley, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1983
Cisobitan in treatment of prostatic cancer. A prospective controlled multicentre studyO Alfthan, L Andersson, P L Esposti, et al.
Bone Marrow Transplantation|March 9, 2018
Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMTZinaida Peric, Stefano Botti, Jacqui Stringer, et al.
Cancer Research|October 28, 2010
DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissueSari Jäämaa, Taija M Af Hällström, Anna Sankila, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Journal of Clinical Pathology|March 16, 2006
Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancerM Branca, C Giorgi, M Ciotti, et al.
Bone Marrow Transplantation|September 15, 2015
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMTT Ruutu, L C de Wreede, A van Biezen, et al.
Pageof 49